Paul Edward Kelly Insider Profile

4 Followers
Paul Edward Kelly , Director at Relmada Therapeutics, holds 212.29K shares in Relmada Therapeutics (Ticker: RLMD). Most recently, Paul Edward Kelly Bought $25,000 shares of Relmada Therapeutics on Sep 11, 2024 for an estimated value of 64.75K.
tipranks
Paul Edward Kelly

Paul Edward Kelly
Relmada Therapeutics (RLMD)
Director

Ranked #129 out of 99,218 Corporate Insiders

Profitable Transactions

100%
5 out of 5 Profitable Transactions

Average Return

+297.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$705K
100.00%
A breakdown of Paul Edward Kelly 's holdings

Insider Roles

Relmada Therapeutics
(RLMD)
Director
Roles that Paul Edward Kelly holds in companies

Most Profitable Insider Trade

Stock:
Relmada Therapeutics
(RLMD)
Rating:Informative Buy
Date:Dec 11, 2018 - Dec 11, 2019
Return:+591.80%
The most profitable trade made by Paul Edward Kelly

Paul Edward Kelly 's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Relmada Therapeutics
Sep 11, 2024
Director
Informative Buy
64.75K
$704.82K
Success Rate for
RLMD
5 out of 5 profitable transactions on
RLMD
100%
Average Return for
RLMD
Average return per transaction on
RLMD
+297.90%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 19, 2018
Informative Buy
$295.91K
-
$0.79
+350.20%
Dec 11, 2018
Informative Buy
$6.05K
-
$1.21
+591.80%
May 15, 2019
Informative Buy
$150.00K
-
$1.50
+521.50%
Aug 19, 2020
Uninformative Buy
$65.36K
-
$5.98
Feb 03, 2021
Uninformative Buy
$56.20K
-
$3.24
List of latest transactions for each holding click on a transaction to see Paul Edward Kelly 's performance on stock

Paul Edward Kelly insider profile FAQ

What is the percentage of profitable transactions made by Paul Edward Kelly ?
The percentage of profitable transactions made by Paul Edward Kelly is 100%.
    What is the average return per transaction made by Paul Edward Kelly ?
    The average return per transaction made by Paul Edward Kelly is 297.90%.
      What stocks does Paul Edward Kelly hold?
      Paul Edward Kelly holds: RLMD stocks.
        What was Paul Edward Kelly ’s latest transaction?
        Paul Edward Kelly latest transaction was an Informative Buy of $64.75K.
          What was Paul Edward Kelly 's most profitable transaction?
          Paul Edward Kelly ’s most profitable transaction was an Informative Buy of RLMD stock on December 11, 2018. The return on the trade was 591.80%.
            What is Paul Edward Kelly 's role in Relmada Therapeutics?
            Paul Edward Kelly 's role in Relmada Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.